News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,222 Results
Type
Article (78155)
Company Profile (721)
Press Release (775316)
Multimedia
Podcasts (219)
Webinars (34)
Section
Business (229710)
Career Advice (3811)
Deals (39581)
Drug Delivery (172)
Drug Development (90283)
Employer Resources (207)
FDA (18305)
Job Trends (17311)
News (391861)
Policy (39251)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3041)
Academic (2)
Accelerated approval (48)
Adcomms (37)
Allergies (179)
Alliances (56468)
ALS (213)
Alzheimer's disease (1902)
Antibody-drug conjugate (ADC) (477)
Approvals (18569)
Artificial intelligence (736)
Autoimmune disease (273)
Automation (56)
Bankruptcy (405)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (231)
Biotechnology (446)
Bladder cancer (190)
Brain cancer (78)
Breast cancer (752)
Cancer (5941)
Cardiovascular disease (514)
Career advice (3276)
Career pathing (48)
CAR-T (345)
CDC (73)
Celiac Disease (2)
Cell therapy (932)
Cervical cancer (46)
Clinical research (77164)
Collaboration (2194)
Company closure (7)
Compensation (1367)
Complete response letters (100)
COVID-19 (3020)
CRISPR (112)
C-suite (1132)
Cystic fibrosis (161)
Data (7648)
Decentralized trials (3)
Denatured (83)
Depression (180)
Dermatology (72)
Diabetes (605)
Diagnostics (7462)
Digital health (58)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (360)
Drug pricing (238)
Drug shortages (39)
Duchenne muscular dystrophy (291)
Earnings (99455)
Editorial (74)
Employer branding (25)
Employer resources (174)
Events (136237)
Executive appointments (1137)
FDA (22026)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1787)
Gene editing (243)
Generative AI (77)
Gene therapy (773)
GLP-1 (1224)
Government (5500)
Grass and pollen (8)
Guidances (407)
Healthcare (21046)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (334)
Immuno-oncology (98)
Indications (168)
Infectious disease (3386)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (144)
Intellectual property (287)
Interviews (747)
IPO (17908)
IRA (61)
Job creations (5051)
Job search strategy (2642)
JPM (73)
Kidney cancer (20)
Labor market (109)
Layoffs (669)
Leadership (48)
Legal (10015)
Liver cancer (106)
Longevity (32)
Lung cancer (793)
Lymphoma (427)
Machine learning (59)
Management (66)
Manufacturing (1070)
MASH (197)
Medical device (15162)
Medtech (15254)
Mergers & acquisitions (22884)
Metabolic disorders (1629)
mRNA (231)
Multiple sclerosis (190)
NASH (24)
Neurodegenerative disease (444)
Neuropsychiatric disorders (121)
Neuroscience (3487)
Neurotech (1)
NextGen: Class of 2026 (7668)
Non-profit (5131)
Now hiring (76)
Obesity (795)
Opinion (364)
Ovarian cancer (213)
Pain (263)
Pancreatic cancer (295)
Parkinson's disease (375)
Partnered (37)
Patents (594)
Patient recruitment (660)
Peanut (66)
People (66705)
Pharmaceutical (131)
Pharmacy benefit managers (36)
Phase 1 (23873)
Phase 2 (33632)
Phase 3 (25320)
Pipeline (7901)
Policy (378)
Postmarket research (3305)
Preclinical (10574)
Press Release (72)
Prostate cancer (300)
Psychedelics (64)
Radiopharmaceuticals (344)
Rare diseases (1146)
Real estate (7269)
Recruiting (81)
Regulatory (29296)
Reports (76)
Research institute (2756)
Resumes & cover letters (593)
Rett syndrome (35)
RNA editing (25)
RSV (98)
Schizophrenia (185)
Series A (299)
Series B (220)
Service/supplier (27)
Sickle cell disease (117)
Special edition (30)
Spinal muscular atrophy (185)
Sponsored (53)
Startups (4269)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (133)
Vaccines (1245)
Venture capital (115)
Weight loss (548)
Women's health (124)
Worklife (24)
Date
Today (173)
Last 7 days (797)
Last 30 days (2969)
Last 365 days (32849)
2026 (10599)
2025 (32703)
2024 (37918)
2023 (42566)
2022 (53928)
2021 (58722)
2020 (57664)
2019 (51317)
2018 (39100)
2017 (36915)
2016 (37887)
2015 (43902)
2014 (38728)
2013 (34881)
2012 (36713)
2011 (36809)
2010 (36472)
Location
Africa (1231)
Alabama (100)
Alaska (7)
Arizona (362)
Arkansas (16)
Asia (50695)
Australia (8697)
California (13178)
Canada (3729)
China (1394)
Colorado (569)
Connecticut (580)
Delaware (399)
Europe (115621)
Florida (1954)
Georgia (432)
Hawaii (4)
Idaho (68)
Illinois (1116)
India (95)
Indiana (618)
Iowa (25)
Japan (530)
Kansas (137)
Kentucky (53)
Louisiana (45)
Maine (87)
Maryland (1618)
Massachusetts (9619)
Michigan (391)
Minnesota (741)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (92)
New Jersey (3534)
New Mexico (33)
New York (3487)
North Carolina (1786)
North Dakota (10)
Northern California (6466)
Ohio (405)
Oklahoma (26)
Oregon (53)
Pennsylvania (2630)
Puerto Rico (29)
Rhode Island (53)
South America (1595)
South Carolina (87)
South Dakota (2)
Southern California (5147)
Tennessee (209)
Texas (2113)
United States (47291)
Utah (396)
Vermont (1)
Virginia (334)
Washington D.C. (88)
Washington State (1088)
West Virginia (4)
Wisconsin (146)
Wyoming (2)
854,222 Results for "vetter pharma fertigung gmbh and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Press Releases
Vetter Recognized as 2026 CDMO Leadership Awards Winner
Independent recognition strengthens Vetter’s position as a trusted, high-performing CDMO • Awards recognize CDMO performance in five categories • Selection is based on quantitative metrics and verified sponsor feedback from biopharma partners • Recognition reflects trust placed in Vetter by industry and customers
March 30, 2026
·
1 min read
Press Releases
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Further advancements in Europe and the US increase capacity and process efficiency ● Construction of new clinical manufacturing facility in Des Plaines on schedule ● Established Skokie site with ongoing strong performance for biotech partners ● Infrastructure upgrades at Austrian site further streamline customers’ path to clinic
April 14, 2026
·
1 min read
Government
RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media
The pharma industry “own Congress, they own the media,” Health Secretary Robert F. Kennedy, Jr. told lawmakers by way of explaining the bad press against FDA Commissioner Marty Makary following the second rejection of Replimune’s advanced melanoma drug.
April 17, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
April 14, 2026
·
1 min read
Press Releases
NervGen Pharma to Participate in the H.C. Wainwright “HCW@Home” Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 13, 2026
·
5 min read
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
The approval of Eli Lilly’s oral obesity drug officially ignites an intense competition with Novo Nordisk’s oral Wegovy; Gilead Sciences and Neurocrine Biosciences keep the M&A train chugging; Trump hits pharma with his long promised tariffs, and the FDA proposes many changes with 2027 budget.
April 8, 2026
·
1 min read
·
Heather McKenzie
Patents
Proliferating Patents, Lawsuits Stave Off Pharmas’ Generic Competitors
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
February 18, 2026
·
4 min read
·
Shawna Williams
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Earnings
On steadier ground, pharma heads into Q1 earnings with deals top of mind
During the pharma earnings season, which begins on Tuesday, Novo Nordisk will report the first revenue numbers from an oral GLP-1 medicine, while other companies are expected to address the FDA, drug pricing and Trump’s new tariffs.
April 14, 2026
·
5 min read
·
Annalee Armstrong
1 of 85,423
Next